Javascript must be enabled to continue!
Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study
View through CrossRef
Abstract
Background
Influenza and tuberculosis both cause significant morbidity and mortality worldwide. Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population.
Methods
A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed. A total of 304 participants were recruited in both groups and followed for a period of 12 weeks. Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.5% in general population. An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI). Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09. All statistical analyses were conducted using R software.
Results
A total of 95 participants developed influenza-like illness (ILI) symptoms. Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group. During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people. The risk of testing positive for influenza A (H1N1)pdm09 was 1.66 times higher in the exposed group compared to the non-exposed group. The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up.
Conclusion
Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination.
Springer Science and Business Media LLC
Title: Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study
Description:
Abstract
Background
Influenza and tuberculosis both cause significant morbidity and mortality worldwide.
Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population.
Methods
A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed.
A total of 304 participants were recruited in both groups and followed for a period of 12 weeks.
Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).
To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.
5% in general population.
An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI).
Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09.
All statistical analyses were conducted using R software.
Results
A total of 95 participants developed influenza-like illness (ILI) symptoms.
Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group.
During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people.
The risk of testing positive for influenza A (H1N1)pdm09 was 1.
66 times higher in the exposed group compared to the non-exposed group.
The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up.
Conclusion
Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination.
Related Results
Effect of human rhinovirus infection in pediatric patients with influenza-like illness on the 2009 pandemic influenza A(H1N1) virus
Effect of human rhinovirus infection in pediatric patients with influenza-like illness on the 2009 pandemic influenza A(H1N1) virus
Background
Some research groups have hypothesized that human rhinoviruses (HRVs) delayed the circulation of the 2009 pandemic influenza A(H1N1) virus (A(H1N1)pdm09) at ...
Phylogenetic analysis of HA and NA genes and clinical characteristics of the co-occurring mutations in HA and NA of influenza A(H1N1)pdm09 viruses during 2015-2017 in Beijing, China
Phylogenetic analysis of HA and NA genes and clinical characteristics of the co-occurring mutations in HA and NA of influenza A(H1N1)pdm09 viruses during 2015-2017 in Beijing, China
Abstract
Background
Influenza A(H1N1)pdm09 viruses have undergone rapid evolution, and in recent years the complementary and antagonistic effects of HA and NA have gathere...
Phylogenetic analysis of HA and NA genes and clinical characteristics of the co-occurring mutations in HA and NA of influenza A(H1N1)pdm09 viruses during 2015-2017 in Beijing, China
Phylogenetic analysis of HA and NA genes and clinical characteristics of the co-occurring mutations in HA and NA of influenza A(H1N1)pdm09 viruses during 2015-2017 in Beijing, China
Abstract
Background: Influenza A(H1N1)pdm09 viruses have undergone rapid evolution, and in recent years the complementary and antagonistic effects of HA and NA have gathere...
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: Borders‐Hemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Introduction. According to the literature, it is known that clinical signs and symptoms of influenza may differ depending on age, the state of the human immune system, the serot...
H1N1-09 Infections In Patients with Hematologic or Oncologic Malignancies: A Single-Centre Experience
H1N1-09 Infections In Patients with Hematologic or Oncologic Malignancies: A Single-Centre Experience
Abstract
Abstract 4866
Introduction
The first pandemic of the 21st century was caused by the novel influenza A (H...
1631. Association Between Type-Specific Influenza Circulation and Incidence of Severe Laboratory-confirmed Cases; Which Subtype Is the Most Virulent?
1631. Association Between Type-Specific Influenza Circulation and Incidence of Severe Laboratory-confirmed Cases; Which Subtype Is the Most Virulent?
Abstract
Background
Excess population mortality during winter is most often associated with influenza A(H3N2), particularly “pne...
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
Antiviral therapy such as Oseltamivir has been recommended for hospitalized children with suspected and confirmed influenza for almost 20 years. The therapy is officially authorize...

